Sireesh Appajosyula

426 total citations
9 papers, 339 citations indexed

About

Sireesh Appajosyula is a scholar working on Oncology, Physiology and Molecular Biology. According to data from OpenAlex, Sireesh Appajosyula has authored 9 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Physiology and 2 papers in Molecular Biology. Recurrent topics in Sireesh Appajosyula's work include Asthma and respiratory diseases (4 papers), Cancer Cells and Metastasis (3 papers) and Allergic Rhinitis and Sensitization (2 papers). Sireesh Appajosyula is often cited by papers focused on Asthma and respiratory diseases (4 papers), Cancer Cells and Metastasis (3 papers) and Allergic Rhinitis and Sensitization (2 papers). Sireesh Appajosyula collaborates with scholars based in United States, India and China. Sireesh Appajosyula's co-authors include William F. Schoenwetter, Chris L. Pashos, Marc Botteman, Leon Dupclay, Suzanne Meeves, Stanley J. Szefler, Hartmut Derendorf, Karl Zech, Shashank Rohatagi and Ruediger Nave and has published in prestigious journals such as Cancer Research, Journal of Allergy and Clinical Immunology and The Journal of Clinical Pharmacology.

In The Last Decade

Sireesh Appajosyula

9 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sireesh Appajosyula United States	5	252	210	103	52	48	9	339
Anders Källén Sweden	9	231 0.9×	44 0.2×	230 2.2×	8 0.2×	5 0.1×	16	361
Haixiong Tang China	10	135 0.5×	21 0.1×	96 0.9×	16 0.3×	18 0.4×	16	324
Ulf Harnest Germany	6	294 1.2×	29 0.1×	245 2.4×	6 0.1×	4 0.1×	10	348
Stefan Leichtl Germany	8	297 1.2×	33 0.2×	224 2.2×	7 0.1×	2 0.0×	11	400
Degenhard Marx Germany	10	153 0.6×	30 0.1×	135 1.3×	3 0.1×	5 0.1×	20	288
Juan Rodríguez‐Coira Spain	7	97 0.4×	62 0.3×	16 0.2×	28 0.5×		10	200
Anna James Sweden	6	127 0.5×	25 0.1×	108 1.0×	4 0.1×	2 0.0×	9	183
Sümeyye Alparslan Bekir Türkiye	5	248 1.0×	54 0.3×	223 2.2×	3 0.1×		14	352
Laura B. Fanning United States	5	47 0.2×	42 0.2×	23 0.2×	19 0.4×		11	244
S. Seubert Germany	9	33 0.1×	78 0.4×	52 0.5×	91 1.8×		28	378

Countries citing papers authored by Sireesh Appajosyula

Since Specialization

Citations

This map shows the geographic impact of Sireesh Appajosyula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sireesh Appajosyula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sireesh Appajosyula more than expected).

Fields of papers citing papers by Sireesh Appajosyula

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sireesh Appajosyula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sireesh Appajosyula. The network helps show where Sireesh Appajosyula may publish in the future.

Co-authorship network of co-authors of Sireesh Appajosyula

This figure shows the co-authorship network connecting the top 25 collaborators of Sireesh Appajosyula. A scholar is included among the top collaborators of Sireesh Appajosyula based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sireesh Appajosyula. Sireesh Appajosyula is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Tiwari, Sachchidanand, Neha Mehrotra, Bożena Korczak, et al.. (2021). Abstract 3107: HSB-1216, A Novel Agent for the Treatment of Chemotherapy-Resistant ES-SCLC. Cancer Research. 81(13_Supplement). 3107–3107. 1 indexed citations

Tiwari, Sachchidanand, Neha Mehrotra, Bożena Korczak, et al.. (2021). Abstract 3082: Synergistic inhibition of TNBC cell growth by novel doxorubicin/salinomycin-encapsulated dual drug-nanoparticles. Cancer Research. 81(13_Supplement). 3082–3082. 1 indexed citations

Kharbanda, Surender, Sireesh Appajosyula, Mark F. Rosenberg, et al.. (2020). Abstract 491: Encapsulation of the stem cell inhibitor Salinomycin in novel QUATRAMER sustained injectable suspension (HSB-1216) for the treatment of small cell lung cancer. Cancer Research. 80(16_Supplement). 491–491. 2 indexed citations

Kharbanda, Surender, et al.. (2020). Abstract 492: A Novel QUATRAMER sustained injectable suspension for the intracellular delivery of Salinomycin, a stem cell inhibitor (HSB-1216), for the treatment of triple negative breast cancer. Cancer Research. 80(16_Supplement). 492–492. 2 indexed citations

Appajosyula, Sireesh, et al.. (2018). Decline in Buprenorphine/Naloxone Prescriptions in a State Medicaid Population Following Formulary Conversion from Suboxone to Bunavail. Advances in Therapy. 35(4). 457–466. 4 indexed citations

Schoenwetter, William F., Leon Dupclay, Sireesh Appajosyula, Marc Botteman, & Chris L. Pashos. (2004). Economic impact and quality-of-life burden of allergic rhinitis. Current Medical Research and Opinion. 20(3). 305–317. 191 indexed citations

Meeves, Suzanne & Sireesh Appajosyula. (2003). Efficacy and safety profile of fexofenadine HCL. Journal of Allergy and Clinical Immunology. 112(4). S69–S77. 38 indexed citations

Rohatagi, Shashank, Sireesh Appajosyula, Hartmut Derendorf, et al.. (2003). Risk‐Benefit Value of Inhaled Glucocorticoids: A Pharmacokinetic/ Pharmacodynamic Perspective. The Journal of Clinical Pharmacology. 44(1). 37–47. 79 indexed citations

Gelfand, Erwin W., Sireesh Appajosyula, & Suzanne Meeves. (2003). Anti-inflammatory activity of H1-receptor antagonists: review of recent experimental research. Current Medical Research and Opinion. 20(1). 73–81. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact